Drug Profile
Eleutherobin
Alternative Names: BMS 196417Latest Information Update: 30 Mar 2008
Price :
$50
*
At a glance
- Originator Scripps Institution of Oceanography
- Developer Bristol-Myers Squibb
- Class Antineoplastics; Diterpenes; Eleutherobins
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer